Skip to main content

Orchid Inks DNA Testing Contract with New Zealand

NEW YORK, April 13 (GenomeWeb News) - Orchid BioSciences Europe will provide DNA testing services to the New Zealand immigration authorities, parent company Orchid BioSciences said today.

 

Under the three-year contract, which is potentially renewable for two years, Orchid will test DNA samples from applicants seeking residency in New Zealand to determine their biological relationships to family members.

 

Under New Zealand law, certain relatives of citizens and permanent residents are allowed to immigrate. DNA testing will be applied to applicants from countries with record systems that do not satisfy the requirements of the New Zealand Immigration Service.

 

Orchid BioSciences Europe, based in Abingdon, UK, already provides immigration DNA testing for the UK and Norway. The company resulted from Orchid's acquisition of Cellmark Diagnostics in 2001.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.